Is remdesivir more effective than Paxlovid? A comparison of COVID-19 antiviral therapies
•
3 min read
While head-to-head clinical trials are limited, leading health organizations often prioritize Paxlovid for high-risk, non-hospitalized patients with mild-to-moderate COVID-19 due to its potent efficacy and oral administration. Understanding the distinct roles and methods of these therapies is crucial when evaluating if remdesivir is more effective than Paxlovid.
